NYU Langone Health: Schizophrenia trials

The registry lists 10 Schizophrenia studies with NYU Langone Health as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 2 4Phase 4 2No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Focused Ultrasound Modulation of the Globus Pallidus Interna in SchizophreniaCompletedNCT05643196Phase 2Results posted
• Levetiracetam in Early PsychosisCompletedNCT03129360Phase 2Results posted
• Biomarkers in First Episode SchizophreniaCompletedNCT02033382Results posted
• D-Cycloserine Augmentation of Cognitive Behavioral Therapy for DelusionsCompletedNCT01981759Phase 4Results posted
• DECIFER: Depression and Citalopram In First Episode RecoveryCompletedNCT01041274Phase 4Results posted
• Imaging Dopamine D2 Agonist Binding Sites in SchizophreniaWithdrawnNCT03999190
• Music to Reduce Use of Smoking in Patients With SchizophreniaCompletedNCT03190161Not applicable
• The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum DisordersCompletedNCT03166098
• NRX-1074 in Early Course SchizophreniaWithdrawnNCT02603458Phase 2
• Targeted Vitamin D Treatment of Schizophrenia-Associated HyperprolinemiaWithdrawnNCT02197286Phase 2